+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Chemotherapy Infusion Pumps Market by Product and Geography - Global Forecast and Analysis 2019-2023 - Product Image

Chemotherapy Infusion Pumps Market by Product and Geography - Global Forecast and Analysis 2019-2023

  • ID: 4787738
  • Report
  • May 2019
  • Region: Global
  • 133 pages
  • TechNavio

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Co.
  • ICU Medical Inc.
  • Smiths Group Plc
  • MORE
Global Chemotherapy Infusion Pumps Market: About this market

Chemotherapy drugs are medical devices used to deliver drugs into the body of a cancer patient in a controlled manner. The chemotherapy infusion pumps market analysis considers the sales of LVPs and syringe pumps and elastomeric pumps. Our analysis also considers the sales of chemotherapy infusion pumps in Asia, Europe, North America, and ROW. In 2018, LVPs and syringe pumps segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the development of smart syringe pumps will play a significant role in the LVPs and syringe pumps segment to maintain its market share. Also, our global chemotherapy infusion pumps market looks at factors such as increasing number of cancer cases and awareness programs, expansion of product ranges through new launches, and a growing number of M&A activities for business expansion. However, high costs associated with chemotherapy, product recalls and discontinuation, and side effects associated with chemotherapy may hinder the growth of the chemotherapy infusion pumps industry over the forecast period.

Global Chemotherapy Infusion Pumps Market: Overview

Growing number of M&A activities for business expansion

The growing prevalence of various types of cancer across the world is increasing M&A activities among vendors in the global chemotherapy infusion pumps market. The M&A activities are helping vendors in expanding their business, strengthen their market position, and improve their sales. The acquisition of small and medium-sized cancer care centers in underdeveloped countries is helping large hospitals to provide cancer treatment by improving the healthcare infrastructure. These developments will increase the consumption of chemotherapy infusion pumps and drive the growth of the global chemotherapy infusion pumps market size at a CAGR of over 6% during the forecast period.

Growing adoption of disposable chemotherapy infusion pumps

Disposable chemotherapy infusion pumps do not require electricity, and they work using a simple principle that controls the flow rate of the fluid. They are widely used in healthcare settings such as hospitals, specialized clinics, and home care settings. Their increasing adoption has led many vendors in the market to shift their focus toward the development of disposable chemotherapy infusion pumps. This is expected to positively impact the growth of the global chemotherapy infusion pumps market size.

Competitive Landscape

With the presence of several players, the global chemotherapy infusion pumps market is moderately fragmented. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several chemotherapy infusion pumps manufacturers, that include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Co., ICU Medical Inc., and Smiths Group Plc.

Also, the chemotherapy infusion pumps market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Co.
  • ICU Medical Inc.
  • Smiths Group Plc
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • LVPs and syringe pumps - Market size and forecast 2018-2023
  • Elastomeric pumps - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Increasing adoption of chemotherapy infusion pumps in homecare and ambulatory settings
  • Growing adoption of disposable chemotherapy infusion pumps
  • Advent of smart infusion pumps for chemotherapy administration
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Co.
  • ICU Medical Inc.
  • Smiths Group Plc
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
PART 15: EXPLORE

List of Exhibits
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: LVPs and syringe pumps - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: LVPs and syringe pumps - Year-over-year growth 2019-2023 (%)
Exhibit 21: Elastomeric pumps - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Elastomeric pumps - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: Malignant neoplasms of colon and lungs in few North American countries 2012 (Incidence
  • rate per 100,000 population)
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Estimated number of hospital discharge rates of in-patients treated with neoplasms in few
  • European countries 2016 (per 100,000 population)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Product launch details and market impact analysis
Exhibit 40: M&A and their market impact analysis
Exhibit 41: Product discontinuation: Overview
Exhibit 42: Product recalls: Overview
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: B. Braun Melsungen AG - Vendor overview
Exhibit 50: B. Braun Melsungen AG - Business segments
Exhibit 51: B. Braun Melsungen AG - Organizational developments
Exhibit 52: B. Braun Melsungen AG - Geographic focus
Exhibit 53: B. Braun Melsungen AG - Segment focus
Exhibit 54: B. Braun Melsungen AG - Key offerings
Exhibit 55: B. Braun Melsungen AG - Key customers
Exhibit 56: Baxter International Inc. - Vendor overview
Exhibit 57: Baxter International Inc. - Business segments
Exhibit 58: Baxter International Inc. - Organizational developments
Exhibit 59: Baxter International Inc. - Geographic focus
Exhibit 60: Baxter International Inc. - Segment focus
Exhibit 61: Baxter International Inc. - Key offerings
Exhibit 62: Baxter International Inc. - Key customers
Exhibit 63: Becton Dickinson and Co. - Vendor overview
Exhibit 64: Becton Dickinson and Co. - Business segments
Exhibit 65: Becton Dickinson and Co. - Organizational developments
Exhibit 66: Becton Dickinson and Co. - Geographic focus
Exhibit 67: Becton Dickinson and Co. - Segment focus
Exhibit 68: Becton Dickinson and Co. - Key offerings
Exhibit 69: Becton Dickinson and Co. - Key customers
Exhibit 70: ICU Medical Inc. - Vendor overview
Exhibit 71: ICU Medical Inc. - Business segments
Exhibit 72: ICU Medical Inc. - Organizational developments
Exhibit 73: ICU Medical Inc. - Geographic focus
Exhibit 74: ICU Medical Inc. - Segment focus
Exhibit 75: ICU Medical Inc. - Key offerings
Exhibit 76: ICU Medical Inc. - Key customers
Exhibit 77: Smiths Group Plc - Vendor overview
Exhibit 78: Smiths Group Plc - Business segments
Exhibit 79: Smiths Group Plc - Organizational developments
Exhibit 80: Smiths Group Plc - Geographic focus
Exhibit 81: Smiths Group Plc - Segment focus
Exhibit 82: Smiths Group Plc - Key offerings
Exhibit 83: Smiths Group Plc - Key customers
Exhibit 84: Validation techniques employed for market sizing
Exhibit 85: Definition of market positioning of vendors
    Note: Product cover images may vary from those shown

    FEATURED COMPANIES

    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Co.
    • ICU Medical Inc.
    • Smiths Group Plc
    • MORE
    The following companies are recognised as the key players in the global chemotherapy infusion pumps market: B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Co., ICU Medical Inc., and Smiths Group Plc.

    Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the growing adoption of disposable chemotherapy infusion pumps.”

    According to the report, one of the major drivers for this market is the growing number of M&A activities for business expansion.

    Further, the report states that one of the major factors hindering the growth of this market is the high costs associated with chemotherapy.

    The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
    Note: Product cover images may vary from those shown
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Co.
    • ICU Medical Inc.
    • Smiths Group Plc
    Note: Product cover images may vary from those shown

    Loading
    LOADING...

    Adroll
    adroll